Neuropharm Share Discussion Threads

[fairdeal2008] 25/8/2009 14:05

bashers have arrived - a good sign

[borchardt] 25/8/2009 14:03

mkt makers letting mug punters buy in just before they smash the price

[muzoman] 25/8/2009 14:02

Lombiff,

I bought into this stock yesterday. Was lucky to get two trades and they did not show on BarcStock trade analysis at all. I also find it strange.

Not to worry. If the MM'S want to play games I believe there are enough clever posters on this board who have caught on and will not sell.

GLA

[lombiff] 25/8/2009 13:57

Thanks FD - haven't looked at Plus yet - don't really understand the different feeds.

What is bizarre is that my trade (through Barclays) doesn't even show on Barclays own trade analysis page (data is probably delayed).

[still waiting] 25/8/2009 13:57

they were short at 9.00am

I think it's a whole lot worse now.

[geng] 25/8/2009 13:57

Barclays will let you buy 100 online but I can sell my whole holding.

No brainer - MM's have virtually no stock - come on boys take it to £1.

However I guess if they have little stock they won't make much if they take it straight to £1

[fairdeal2008] 25/8/2009 13:56

dont worry bout the mm messing with the prices up and down, there is a stock shortage here imho

[fairdeal2008] 25/8/2009 13:55

yes down to 2000 online again - move up coming imho - this will be the big one hopefully

[still waiting] 25/8/2009 13:54

39p offer about to go..

simply too much buying for mm's

;-)

[geng] 25/8/2009 13:53

Ha Ha - trying to buy a few more and can't

Big leg up coming I think

[fairdeal2008] 25/8/2009 13:52

Lombiff here are the last 5 trades on plus - it is showing here:

Trade Date Time Price Volume Type Consid.
25/08/2009 14:43:36 38.50 1,002 O 385.77
25/08/2009 14:38:55 38.50 1,298 O 499.73
25/08/2009 14:36:18 38.50 10,000 O 3,850.00
25/08/2009 14:32:16 38.50 5,194 O 1,999.69
25/08/2009 14:31:22 35.50 2,889 O 1,025.60

[lombiff] 25/8/2009 13:51

On-line buy limit back down to 5K with Barclays

[mike_f] 25/8/2009 13:50

Someone stock piling? Ready for next push up IMO! GLA

[lombiff] 25/8/2009 13:49

Serves them right - it was too tempting!! My 10K at 38.5p not showing yet.

[fairdeal2008] 25/8/2009 13:48

big buys coming through now 19k and 18k

[still waiting] 25/8/2009 13:46

they didn't get any sellers

lol.

[fairdeal2008] 25/8/2009 13:44

off we go again....

[mike_f] 25/8/2009 13:42

Lombiff, well done mate, all the way to £1, here we come...

[fairdeal2008] 25/8/2009 13:41

nice opportunity to pick a few up imho

[lombiff] 25/8/2009 13:41

blatant shake - I've just bought another 10K - gap up in the morning.

All IMHO of course.

[fairdeal2008] 25/8/2009 13:39

Sorry here is the real HZM link referred to above:

[mike_f] 25/8/2009 13:39

'Analyst Robin Davison at Edison Investment Research said possible partners might include the likes of U.S.-based Cephalon Inc ( CEPH - news - people ), Britain's Shire ( SHPGY - news - people ) Plc or Denmark's Lundbeck A/S. Neuropharm refused to comment'

[fairdeal2008] 25/8/2009 13:36

Think I keep mentioning NPL 2008 and should say NPL 2003 .....

[fairdeal2008] 25/8/2009 13:35

Key points:

- Pharma company, developing drugs for Autism, ADHD and OCD, neurological conditions;

- Current market cap (at 21.5p mid) is approx £6.5 million, compared to cash in the bank of around £7million;

- Market cap crashed February 2009 when rns released noting failure of key drug trials to achieve primary end point;

- Trial result unexpected, as previous trials all successful, some query over dosage levels in active group or whether problems with placebo group. Company looking for a major pharma to partner ongoing development (i.e. in simple terms - dont consider this programme totally failed);

- Edison report 18th March 2009 values company at 40p per share if NPL 2008 a total failure or up to £1.60 a share if NPL 2008 proves to have just 20% success;

- Has been a seller (or two) in the background keeping the price low but looks like they are now clear;

- Company should announce result of NPL- 2008 research review in due course. If a partner is secured the share price expected to increase substantially. Even if you write off NPL-2008 company (per Edison) still valued at 40p per share right now and other programmes for Fragile X and Pediatric OCD have development value.

Portfolio:

Autism - NPL- 2008:



Fragile X:



Pediatric OCD:



Seems like this share was hugely oversold in February. We are due an update in H2 of 2009 regarding NPL-2003 and they are looking at getting the JV signed before the Autumn according to recent RNS.